🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to investigate the mechanism of action for lige...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2020-08-05
Trial ID
NCT04513548
Treatments Being Tested
A safety extension study to evaluate the long-term safety of QGE031 240 mg ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-05-24
Trial ID
NCT02649218
Treatments Being Tested
This study planned to assess the effect on the reduction in rate of severe ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2015-09
Trial ID
NCT02336425
This clinical study was designed to evaluate the pharmacokinetics, safety a...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-08-01
Trial ID
NCT03437278
Treatments Being Tested
This study will evaluate the efficacy of QGE031 compared to omalizumab in p...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-11
Trial ID
NCT01703312
Treatments Being Tested
This study planned to assess long-term safety of QGE031 during 12 months tr...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-03-27
Trial ID
NCT02075008
Treatments Being Tested
This is a placebo and active-controlled phase 2b dose-finding study to eval...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-07-15
Trial ID
NCT02477332
Treatments Being Tested
This was an extension study to evaluate the long-term safety and efficacy o...
Status
Terminated
Location
Allervie Clinical Research
Start Date
2023-04-27
Trial ID
NCT05678959
Treatments Being Tested
The study will assess the safety and efficacy of QGE031 in the treatment of...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-01-05
Trial ID
NCT01552629
Treatments Being Tested
This was a placebo controlled, phase 3 study designed to evaluate the effic...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2021-11-16
Trial ID
NCT05024058
Treatments Being Tested